Philips Introduces Next Generation of IntelliSpace Cardiovascular Informatics Platform at HIMSS 2018

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of IntelliSpace Cardiovascular 3.1, its next-generation cardiovascular image and information management system. Designed to help streamline workflow and improve operational performance throughout the cardiovascular service line, the latest version features enhanced security and enterprise protocols, seamless access to Philips' QLAB and TOMTEC software tools, and the addition of browser-based reporting of stress echocardiogram (stress echo) tests.

IntelliSpace Cardiovascular provides clinicians with a single point of access anytime and virtually anywhere to support informed decision-support by providing a comprehensive overview of a patient. Through its web-based echo reporting, IntelliSpace Cardiovascular delivers diagnostic quality viewing of adult and stress echo images in a browser environment. Building on Philips' commitment to security, this latest edition of IntelliSpace Cardiovascular also features enhanced security protocols in line with industry-leading standards to meet the ever-growing needs of health systems to help manage cyber threats.

"Clinicians are spending more and more time behind their computer screens, accessing a variety of programs and tools to ensure they are capturing the complete picture of a patient's health - a frustrating and time-consuming process," said Paul Melman, MD, cardiologist at ETZ (Elisabeth-TweeSteden Ziekenhuis, a hospital in Tilburg, The Netherlands). "IntelliSpace Cardiovascular empowers our care teams with integrated, comprehensive data within one system that arms them with the relevant actionable data."

The latest iteration of IntelliSpace Cardiovascular now supports tight integration with the full Philips Cardiovascular Informatics portfolio including TOMTEC, Xper IM, IntelliSpace Portal and IntelliSpace ECG. In supporting Philips' commitment to interoperability and open systems, IntelliSpace Cardiovascular also interfaces with multiple third-party applications, including scheduling systems, lab applications, and specialty PACS. This comprehensive insight helps reduce the time and frustration related to accessing multiple systems and allows clinicians to search for specific information - like previous test results - across systems in a single workspace. By aggregating all of this data across the health continuum, clinicians are able to make more informed decisions and better collaborate with peers, while having a seamlessly integrated experience.

"Philips is committed to providing health systems with the tools needed to enhance clinical excellence through improved decision-making, while meeting the needs and security requirements of their IT teams," said Amir Hasan, Business Leader, Cardiology Informatics, Philips. "By securely aggregating data from across the cardiovascular service line, our aim is to help our customers maximize their resources, improve staff satisfaction and help drive operational and financial efficiency."

Philips IntelliSpace Cardiovascular is available globally. In North America and other select markets, Philips IntelliSpace Cardiovascular is also available as part of Philips IntelliSpace Enterprise Edition.

For more information on IntelliSpace Cardiovascular and Philips' full suite of integrated solutions driving operational efficiency and clinical excellence, visit booth #3812 at the 2018 Annual HIMSS Conference & Exhibition taking place March 5-9 at the Sands Expo in Las Vegas, NV.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips’ health technology portfolio generated 2017 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...